ETON:NASDAQ, Eton Pharmaceuticals, Inc.

Why ETON stock rose on November 9

Eton Pharmaceuticals, Inc. rose 14.0% on Monday, November 9, 2026, on 1,123,792 shares. No headline about ETON came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

ETON stock overview

Eton Pharmaceuticals, Inc. (ETON:NASDAQ) closed at $63.93 on November 13, 2026, up 4.04% on the day. The stock trades 9.5% below its 52-week high of $70.64 and 348.0% above its 52-week low of $14.27. Over the past year, it gained 277.4%. Eton Pharmaceuticals, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$63.93
Day change
+4.04%
Volume
600,692
Average volume
618,881
Market cap
1B+
52-week range
$14.27 – $70.64
50-day average
$55.18
200-day average
$37.61

Price action over the past year

In 252 trading sessions since November 13, 2025, ETON closed higher on 138 days (55%). Its best day was August 14, 2026 (+44.26%) and its worst was September 30, 2026 (-13.01%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

ETON news

About Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products utilizing the FDA's 505(b)(2) regulatory pathway, to fulfill an unmet patient need. It has a diversified pipeline of around eight product candidates in various stages of development.

Similar stocks

Find more stocks like ETON with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.